Cargando…
Predicting virological decay in patients starting combination antiretroviral therapy
OBJECTIVE: Model trajectories of viral load measurements from time of starting combination antiretroviral therapy (cART), and use the model to predict whether patients will achieve suppressed viral load (≤200 copies/ml) within 6-months of starting cART. DESIGN: Prospective cohort study including HIV...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933580/ https://www.ncbi.nlm.nih.gov/pubmed/27124894 http://dx.doi.org/10.1097/QAD.0000000000001125 |
Ejemplares similares
-
Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013) -
Factors Associated With Early Virological Response in HIV-Infected Individuals Starting Antiretroviral Therapy in Brazil (2014–2015): Results From a Large HIV Surveillance Cohort
por: Meireles, Mariana V., et al.
Publicado: (2018) -
Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4(+) cell counts: findings from a cluster-randomized trial
por: Woodd, Susannah L., et al.
Publicado: (2014) -
Mortality and causes of death in people living with HIV in the era of combination antiretroviral therapy compared with the general population in Japan
por: Nishijima, Takeshi, et al.
Publicado: (2020) -
Adherence to oral antiretroviral therapy in Canada, 2010–2020
por: Angel, Jonathan B., et al.
Publicado: (2023)